The Australian MRI-Linac Program: Transforming the Science and Clinical Practice of Cancer Radiotherapy

澳大利亚 MRI-Linac 计划：改变癌症放射治疗的科学和临床实践

• 批准号: nhmrc : 1132471
• 负责人: Prof Michael Barton
• 金额: $ 473.39万
• 依托单位: Australian National University
• 依托单位国家: 澳大利亚
• 项目类别: Program Grants
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/australian-mri-linac-cancer-radiotherapy/948655
• 关键词: Australian; MRI; Linac; Program; Transforming

Radiotherapy is indicated for 48% of cancer patients. The Australian MRI-Linac Program will change the science and clinical practice of radiotherapy by explicitly targeting the dynamic anatomy and physiology of cancer, increasing cancer control and decreasing treatment side effects. Successful completion of this program will have a direct impact on the treatment and lives of Australian cancer patients in the foreseeable future.

48%的癌症患者需要接受放射治疗。澳大利亚核磁共振-直线加速器计划将明确针对癌症的动态解剖学和生理学，加强癌症控制，减少治疗副作用，从而改变放射治疗的科学和临床实践。该项目的顺利完成将在可预见的未来对澳大利亚癌症患者的治疗和生活产生直接影响。